José Arquímides Castro Del Pino has a bachelor’s degree in pharmaceutical sciences from Havana University. He has expertise in mammalian cell culture and fermentation, medium development, purification of mAbs, and glycoproteins. He is the Head of the R&D BioProcess Development Department at the Center of Molecular Immunology in Havana.
Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseasesSparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061 and chronic conditions such as cancer